Evolent Health (EVH) Short-term Investments (2015 - 2026)

Evolent Health has reported Short-term Investments for 12 years, with the latest figure at $24.0 million in Q1 2026.

• For the quarter ending Q1 2026, Short-term Investments rose 47.65% year-over-year to $24.0 million; the trailing twelve-month figure through Mar 2026 stood at $24.0 million (up 47.65% YoY), and the FY2025 full-year result was $26.1 million, down 55.93% from the prior year.
• Short-term Investments for Q1 2026 stood at $24.0 million, down from $26.1 million in the prior quarter.
• The five-year high for Short-term Investments was $74.4 million in Q2 2022, with the low at $13.8 million in Q4 2023.
• Average Short-term Investments over 5 years is $30.7 million, with a median of $24.0 million recorded in 2026.
• Year-over-year, Short-term Investments plunged 80.85% in 2022 and soared 330.67% in 2024.
• Tracing EVH's Short-term Investments over 5 years: stood at $14.5 million in 2022, then retreated by 5.0% to $13.8 million in 2023, then surged by 330.67% to $59.3 million in 2024, then tumbled by 55.93% to $26.1 million in 2025, then declined by 8.25% to $24.0 million in 2026.
• The last three Short-term Investments figures came in at $24.0 million (Q1 2026), $26.1 million (Q4 2025), and $23.7 million (Q3 2025), per Business Quant data.

Peer Comparison